Trials / Completed
CompletedNCT02200705
Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- IceCure Medical Ltd. · Industry
- Sex
- Female
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ice-Sense3TM/ ProSenseTM |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2024-03-17
- Completion
- 2024-05-26
- First posted
- 2014-07-25
- Last updated
- 2025-04-30
- Results posted
- 2025-04-30
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02200705. Inclusion in this directory is not an endorsement.